COMPASS Pathways plc announces financial results and business highlights for the Q1 2021 May 13, 2021
Center to Study the Neuroscience of Psychedelics Launches at Massachusetts General Hospital May 9, 2021
MINDCURE Files Provisional Patent Application For iSTRYM, its Digital Therapeutics (DTx) SaaS Platform Mar 31, 2021
Pandemic Provides Opportunity for Evaluation of Mental Health; MindCure and MindMed Lead With Ibogaine Mar 8, 2021
Numinus’ Dr Evan Wood: There is Nothing Like Psychedelics to Treat Mental Health Challenges Feb 22, 2021